Biocon Biologics Secures Health Canada Approval for Yesintek™ and Yesintek™ I.V. (Ustekinumab), Biosimilar to Stelara®.
365telugu.com online news, october 23rd,2025: Biocon Biologics Ltd (BBL), a global leader in biosimilars and a subsidiary of Biocon Ltd (BSE: 532523, NSE: BIOCON),